Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
1.
J Appl Toxicol ; 35(2): 116-23, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25291712

ABSTRACT

This paper reviews the blood-brain barrier (BBB) penetration of newly developed pyridinium aldoximes. Pyridinium aldoximes are highly charged hydrophilic compounds used in the treatment of subjects exposed to organophosphonates because they are effective as acetylcholinesterase reactivators. Pyridinium aldoximes have antidotal effects against poisoning with cholinesterase inhibitors, a frequent problem affecting people working with organophosphate-based insecticides and pesticides. Toxic organophosphonate products such as sarin and tabun can be used by terrorists as chemical warfare agents. This poses a severe challenge to all innocent and peace-loving people worldwide. This review gives a brief summary of BBB transporters and description of the current in vitro and in vivo methods for the characterization of BBB penetration of established and novel pyridinium aldoximes. The authors provide a putative mechanism of penetration, outline some future ways of formulation and discuss the possible advantages and disadvantages of increasing BBB penetration.


Subject(s)
Blood-Brain Barrier/metabolism , Cholinesterase Reactivators/pharmacokinetics , Oximes/pharmacokinetics , Pyridinium Compounds/pharmacokinetics , Animals , Antidotes/pharmacokinetics , Antidotes/therapeutic use , Humans , Organophosphate Poisoning/drug therapy
2.
Neurosci Lett ; 504(3): 195-8, 2011 Oct 31.
Article in English | MEDLINE | ID: mdl-21945541

ABSTRACT

The outer hair cells of organ of Corti are innervated by the efferent neurons of medial olivocochlear neurons (MOC) of the brainstem which modify the cochlear auditory processing and sensitivity. Most of the MOC neurons are excited by a dominant ear and only a small portion of them is excited by both ears resulting in a binaural facilitation. The functional role of the feedback system between the organ of Corti and the cochlear efferent neurons is the protection of the ear from acoustic injury. The rapid impulse propagation in the bilateral olivocochlear system is suggestive of an electrotonic interaction between the bilateral olivocochlear neurons. The morphological background of the MOC pathway is not yet completely characterized. Therefore, we have labeled the bilateral cochlear nerves with different neuronal tracers in guinea pigs. In the anesthetized animals the cochlear nerves were exposed in the basal part of the modiolus and labeled simultaneously with different retrograde fluorescent tracers. By using confocal laser scanning microscope we could detect close appositions between the dendrites of the neurons of bilateral MOC. The distance between the neighboring profiles suggested close membrane appositions without interposing glial elements. These connections might serve as one of the underlying mechanisms of the binaural facilitation mediated by the olivocochlear system.


Subject(s)
Auditory Pathways/ultrastructure , Dendrites/ultrastructure , Neurons, Efferent/ultrastructure , Olivary Nucleus/cytology , Organ of Corti/cytology , Animals , Auditory Perception , Axonal Transport , Biotin/analogs & derivatives , Biotin/pharmacokinetics , Dextrans/pharmacokinetics , Dominance, Cerebral , Female , Fluoresceins/pharmacokinetics , Fluorescent Dyes/pharmacokinetics , Guinea Pigs , Hair Cells, Auditory, Outer/ultrastructure , Male , Spiral Ganglion/cytology
3.
Curr Med Chem ; 17(6): 517-51, 2010.
Article in English | MEDLINE | ID: mdl-20015035

ABSTRACT

Diabetes mellitus is a common disease and contributes to a high degree of morbidity and mortality. Cardiovascular complications, including diabetic cardiomyopathy are major causes of morbidity and mortality in diabetic patients. Diabetic cardiomyopathy is a condition that affects the myocardium, primarily. It is not necessarily associated with ischemic heart disease, high blood pressure, valvular or congenital anomalies. The pathology of diabetic cardiomyopathy includes interstitial fibrosis, apoptosis of cardiomyocytes, abnormal energy utilization, small vessel disease and cardiac neuropathy. These pathologies are induced by hyperglycemia and oxidative stress. Biochemical as well as electrolyte changes, especially reduced calcium availability also occurs in the myocardium of diabetic patients. The abnormal structure and biochemistry of the myocardium result in functional problems such as diastolic and systolic dysfunctions, which may cause symptoms of dyspnea and inability to tolerate exercise. No single specific therapeutic agent can treat diabetic cardiomyopathy because once the disease is overt, the management may require a variety of approaches such as risk factors and lifestyle modification, glucose control (insulin, alpha glucosidase inhibitors, sulfonylureas, biguanides, meglitinides, thiazolidinediones and dipeptidyl peptidase 4 (DPP-4) inhibitors); hormones (IGF-1); ACE inhibitors (captopril, enalapril); angiotensin II receptor antagonists (losartan, olmesartan); beta adrenoreceptor antagonists (acebutolol, carvedilol); peptides (adrenomedullin); endothelin-1 receptor antagonists (bosentan, tezosentan); calcium channel blockers (amlodipine, verapamil); antioxidants (methalothionein, alpha tocopherol, alpha lipoic acid) and antihyperlipidemic drugs (simvastatin, fenofibrate, ezetimibe) to effectively treat patients with diabetic cardiomyopathy.


Subject(s)
Cardiomyopathies/drug therapy , Diabetes Complications/drug therapy , Diabetes Mellitus/drug therapy , Adrenergic beta-Antagonists/chemistry , Adrenergic beta-Antagonists/therapeutic use , Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/chemistry , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Calcium Channel Blockers/chemistry , Calcium Channel Blockers/therapeutic use , Cardiomyopathies/etiology , Endothelin-1/antagonists & inhibitors , Endothelin-1/metabolism , Fenofibrate/analogs & derivatives , Fenofibrate/chemistry , Fenofibrate/therapeutic use , Humans , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Peroxisome Proliferator-Activated Receptors/antagonists & inhibitors , Peroxisome Proliferator-Activated Receptors/metabolism , Receptors, Angiotensin/metabolism
4.
Cytometry A ; 73(3): 246-53, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18163469

ABSTRACT

Flow cytometry enables the sequential determination of calcium levels in millions of stimulated lymphocytes over a short period of time. Current algorithms available are not suitable for the statistical analysis of this large amount of data. The authors aimed to develop a robust algorithm that fits a function to median values of measured data and provides an opportunity for statistical comparison between different calcium-flux measurements. The alteration of calcium signal was monitored in CD4+ cells loaded with calcium binding fluorescent dyes and stimulated with phytohemagglutinin; the alteration of calcium signal was monitored for 10 minutes. The authors also reanalyzed published calcium-flux data of CD3+ cells and Jurkat cells stimulated with different concentrations of anti-CD3 and thapsigargin. The authors fitted different functions to the medians of data per time unit and identified hormesis function as the best fitting one. On the basis of the optimally fitting function, the authors calculated the most relevant biological descriptors such as starting value, peak, time to reach the maximum, and time to reach 50% of maximum before and after the peak. Statistically significant differences in cell activation kinetics at different stimulatory concentrations were also demonstrated. This approach enables us to characterize the kinetics and distribution of calcium-flux data derived by flow cytometry and may be a reliable tool for the characterization of lymphocyte activation (for details see: http://calciumflux.intralab.eu).


Subject(s)
Calcium/physiology , Flow Cytometry/methods , Lymphocyte Activation/immunology , Lymphocytes/cytology , Lymphocytes/immunology , Adult , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Lymphocytes/metabolism
5.
J Clin Pathol ; 60(3): 303-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16714396

ABSTRACT

BACKGROUND: Survivin, a novel member of the inhibitor of apoptosis family, plays an important role in cell cycle regulation. A common polymorphism at the survivin gene promoter (G/C at position 31) was shown to be correlated with survivin gene expression in cancer cell lines. AIM: To investigate whether this polymorphism could be involved in the development of human papillomavirus (HPV)-associated cervical carcinoma. METHODS: Survivin promoter polymorphism was detected in patients with cervical cancer, in patients with equivocal cytological atypia and in a control population using polymerase chain reaction (PCR-restriction fragment length polymorphism (RFLP) and PCR-single strand conformation polymorphism analysis. HPV was typed in patients with cervical cancer and cytological atypia using PCR-RFLP. RESULTS: No statistically significant differences were found in the genotype distributions of the survivin promoter variants among our study groups. CONCLUSIONS: The survivin promoter polymorphism at position 31 may not represent an increased risk for the development of cervical cancer, at least in the population studied here.


Subject(s)
Cell Transformation, Neoplastic/genetics , Microtubule-Associated Proteins/genetics , Neoplasm Proteins/genetics , Polymorphism, Genetic , Uterine Cervical Neoplasms/genetics , Cell Transformation, Neoplastic/metabolism , Female , Genetic Predisposition to Disease , Humans , Inhibitor of Apoptosis Proteins , Microtubule-Associated Proteins/metabolism , Neoplasm Proteins/metabolism , Papillomavirus Infections/complications , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic/genetics , Survivin , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/virology
6.
Anal Bioanal Chem ; 384(7-8): 1506-10, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16532310

ABSTRACT

The biological importance of dehydroepiandrosterone (DHEA) is reflected by the fact that DHEA is a crucial precursor of the biosynthesis of the steroidal sex hormones. Simultaneous separation of DHEA, dehydroepiandrosterone sulfate (DHEA-S), pregnenolone, androstenedione and testosterone has been accomplished by reversed-phase ion-pair high-performance liquid chromatography (RP-IP-HPLC) based on isocratic elution applying circular dichroism (CD) detection at 295 nm. Addition of tetrabutylammonium hydrogensulfate to the mobile phase increases the retention of DHEA-S on the C8-silica column by an apparent ion-pairing mechanism without affecting the retention of the other (non-ionic) steroids. CD spectroscopy provides highly selective detection of compounds possessing optically active absorption bands and the separation is even more selective in the higher wavelength range applied. The linearity of the steroid concentration (c, mg mL(-1)) versus peak area was tested in the concentration range of 0.5-2 mg mL(-1) (injected quantities were 10-40 microg). The relative standard deviation (RSD) values for DHEA and DHEA-S indicated a good intra-assay and inter-assay precision of the method.


Subject(s)
Chromatography, High Pressure Liquid/methods , Circular Dichroism/methods , Clinical Laboratory Techniques , Dehydroepiandrosterone/analysis , Steroids/analysis , Chromatography/methods , Dehydroepiandrosterone/blood , Ions , Models, Chemical , Reproducibility of Results , Steroids/blood , Testosterone/analysis , Testosterone/blood , Time Factors
7.
Proc Natl Acad Sci U S A ; 102(25): 9038-43, 2005 Jun 21.
Article in English | MEDLINE | ID: mdl-15947074

ABSTRACT

Presynaptic inhibition of primary muscle spindle (group Ia) afferent terminals in motor nuclei of the spinal cord plays an important role in regulating motor output and is produced by a population of GABAergic axon terminals known as P boutons. Despite extensive investigation, the cells that mediate this control have not yet been identified. In this work, we use immunocytochemistry with confocal microscopy and EM to demonstrate that P boutons can be distinguished from other GABAergic terminals in the ventral horn of rat and mouse spinal cord by their high level of the glutamic acid decarboxylase (GAD) 65 isoform of GAD. By carrying out retrograde labeling from lamina IX in mice that express green fluorescent protein under the control of the GAD65 promoter, we provide evidence that the cells of origin of the P boutons are located in the medial part of laminae V and VI. Our results suggest that P boutons represent the major output of these cells within the ventral horn and are consistent with the view that presynaptic inhibition of proprioceptive afferents is mediated by specific populations of interneurons. They also provide a means of identifying P boutons that will be important in studies of the organization of presynaptic control of Ia afferents.


Subject(s)
Glutamate Decarboxylase/metabolism , Isoenzymes/metabolism , Posterior Horn Cells/enzymology , Spinal Cord/enzymology , Afferent Pathways/physiology , Animals , Genes, Reporter , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Male , Mice , Posterior Horn Cells/cytology , Posterior Horn Cells/ultrastructure , Rats , Rats, Sprague-Dawley , Spinal Cord/ultrastructure , gamma-Aminobutyric Acid/metabolism
8.
Arch Virol ; 149(12): 2379-92, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15290353

ABSTRACT

The effect of the human papillomavirus type 16 (HPV 16) E6 and E7 proteins was studied on the transcriptional activity of the human transforming growth factor beta2 (TGF-beta) promoter in different cell lines. Luciferase tests were performed after co-transfection of cells with TGF-beta2 reporter constructs and HPV 16 E6 or E7 expression vectors. HPV 16 E7, but not E6 significantly repressed TGF-beta2 promoter activity in NIH/3T3 cells, which have wild-type p53 and pRb proteins. The repressive effect of HPV 16 E7 on the transcriptional activity of the TGF-beta2 promoter could be localized to the promoter region -528 to -251 relative to the transcriptional start site. Ability of E7 to bind pRb was necessary to inhibit the TGF-beta2 promoter. Over-expression of the transcription factor E2F-1 had an effect on the TGF-beta2 promoter similar to that of E7, which may indicate that HPV 16 E7 represses the TGF-beta2 promoter by releasing E2F from pRb.


Subject(s)
Oncogene Proteins, Viral/physiology , Papillomaviridae/physiology , Repressor Proteins/physiology , Transforming Growth Factor beta/genetics , 3T3 Cells , Animals , Cell Line, Tumor , Down-Regulation , Gene Expression Regulation, Viral/physiology , Genes, Reporter , HeLa Cells , Humans , Mice , Papillomavirus E7 Proteins , Promoter Regions, Genetic , Protein Binding , Transcription, Genetic/physiology , Transforming Growth Factor beta/biosynthesis
9.
Eur J Cardiovasc Prev Rehabil ; 10(5): 319-27, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14663293

ABSTRACT

There is now clear scientific evidence linking regular aerobic physical activity to a significant cardiovascular risk reduction, and a sedentary lifestyle is currently considered one of the five major risk factors for cardiovascular disease. In the European Union, available data seem to indicate that less than 50% of the citizens are involved in regular aerobic leisure-time and/or occupational physical activity, and that the observed increasing prevalence of obesity is associated with a sedentary lifestyle. It seems reasonable therefore to provide institutions, health services, and individuals with information able to implement effective strategies for the adoption of a physically active lifestyle and for helping people to effectively incorporate physical activity into their daily life both in the primary and the secondary prevention settings. This paper summarizes the available scientific evidence dealing with the relationship between physical activity and cardiovascular health in primary and secondary prevention, and focuses on the preventive effects of aerobic physical activity, whose health benefits have been extensively documented.


Subject(s)
Cardiovascular Diseases/prevention & control , Exercise , Health Behavior , Cardiovascular Diseases/epidemiology , Coronary Disease/epidemiology , Coronary Disease/prevention & control , Energy Metabolism , Health Promotion , Humans , Life Style , Physical Fitness , Practice Guidelines as Topic , Risk Factors
10.
Eur Heart J ; 24(13): 1273-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12831822

ABSTRACT

The purpose of this statement is to provide specific recommendations in regard to evaluation and intervention in each of the core components of cardiac rehabilitation (CR) to assist CR staff in the design and development of their programmes; the statement should also assist health care providers, insurers, policy makers and consumers in the recognition of the comprehensive nature of such programmes. Those charged with responsibility for secondary prevention of cardiovascular disease, whether at European, at national or at individual centre level, need to consider where and how structured programmes of CR can be delivered to the large constituency of patients now considered eligible for CR.


Subject(s)
Heart Diseases/prevention & control , Europe , Exercise Therapy , Exercise Tolerance , Heart Diseases/rehabilitation , Humans , Life Style , Risk Reduction Behavior , Stress, Psychological/prevention & control
11.
Arch Virol ; 148(5): 841-51, 2003 May.
Article in English | MEDLINE | ID: mdl-12721794

ABSTRACT

TT virus (TTV) genogroup 1 infection has an increased prevalence in solid organ transplant recipients. In this study, the presence of TTV in renal transplant recipients was examined by two PCR methods, one capable of detecting most TTV genotypes (UTR-PCR), the other specific to genogroup 1 (N22-PCR). The N22-PCR detected TTV in 57% (53/92) of the renal transplant patients and in 20% (13/66) of the healthy individuals, while the prevalence of TTV with the UTR-PCR was above 90% in both the control and the patient groups. The N22-PCR was used in longitudinal studies of 31 renal transplant recipients, these PCR products were sequenced and aligned. TTV status was not associated with the patients' age at transplantation, male to female ratio and the time lag between kidney transplantation and the TTV test. During the follow-up consistent TTV status was found in 26 patients, while two initially TTV positive patients converted to negative and three initially negative patients converted to positive. The TTV variants varied among the tested patients, but were the same in the consecutive samples of each patient, indicating that TTV infection was persistent in renal transplant recipients and novel infection occurred rarely in the post-transplant period.


Subject(s)
Genetic Variation , Kidney Transplantation , Torque teno virus/genetics , Torque teno virus/isolation & purification , Adolescent , Adult , DNA Virus Infections/epidemiology , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Phylogeny , Polymorphism, Single-Stranded Conformational , Prevalence
12.
Eur J Cancer ; 37(15): 1946-52, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11576852

ABSTRACT

Transcription of the E6 and E7 viral oncogenes of human papillomavirus (HPV) type 16 is regulated by the P97 major early promoter, and enhancer and silencer elements found in the long control region (LCR). In this study, we tested the transcriptional activity of natural HPV 16 variants having long deletions in the LCR. The HPV 16 LCR regions were amplified from invasive cervical cancer specimens, and cloned into the reporter vector pALuc. Transcriptional activity of the different clones was measured by luciferase test after transient transfection into HeLa cells. The deletions found in the LCR encompassed parts of the enhancer and either the YY1-specific silencer alone or together with the CDP-specific silencer. The transcriptional activity of these deletion variants were usually reduced compared with that of the corresponding full-length clones. However, a deletion variant lacking the whole enhancer and both silencer regions retained substantial enhancer activity on the P97 promoter. These results point to the existence of a novel context-dependent enhancer element in the 5' LCR of HPV 16.


Subject(s)
Gene Deletion , Papillomaviridae/genetics , Transcription, Genetic , Uterine Cervical Neoplasms/virology , DNA, Viral/genetics , Enhancer Elements, Genetic , Female , Gene Expression Regulation, Viral , Gene Silencing , HeLa Cells , Humans , Papillomaviridae/classification
13.
J Med Virol ; 64(4): 526-30, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11468739

ABSTRACT

Sera of blood donors were investigated by a peptide ELISA and indirect immunofluorescence assay to assess the prevalence of HHV-8 infection in the Hungarian population. A 14 amino acid long synthetic oligopeptide from the carboxyterminus of orf65/small virus capsid antigen was used as antigen in the ELISA. ELISA results were confirmed by recombinant orf65 antigen Western blot. Antibodies to the latent nuclear antigen were detected by the immunofluorescence assay. Nine of 12 sera obtained from patients with classical Kaposi sarcoma were reactive by ELISA whereas all were positive by immunofluorescence. Four of 482 (0.83%) healthy blood donors had anti-orf65 peptide antibodies and 17/1089 (1.56%) had antibodies to the latent nuclear antigen. In a group of children ages 1-14 years, antibodies to the latent nuclear antigen (0/29) were not detected. The prevalence of antibodies to the latent nuclear antigen showed a moderate but significant increase in correlation with senescence. In the Kaposi sarcoma patients, the titre of antibodies to the latent nuclear antigen was significantly higher than in the healthy seropositive donors. The overall HHV-8 seroprevalence by the two assays was 2.28% (11/482) in the Hungarian blood donor group.


Subject(s)
Antibodies, Viral/blood , Blood Donors , Herpesvirus 8, Human/immunology , Phosphoproteins , Adolescent , Adult , Age Factors , Antigens, Viral/immunology , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Humans , Hungary/epidemiology , Infant , Male , Middle Aged , Nuclear Proteins/immunology , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/virology , Seroepidemiologic Studies , Viral Proteins/immunology
14.
Acta Biol Hung ; 52(1): 35-45, 2001.
Article in English | MEDLINE | ID: mdl-11396840

ABSTRACT

The effect of plasma glucose concentration on the cerebral uptake of [18F]-fluorodeoxy-D-glucose (FDG) was studied in a broad concentration range in a rabbit brain model using dynamic FDG PET measurements. Hypoglycemic and hyperglycemic conditions were maintained by manipulating plasma glucose applying i.v. glucose or insulin load. FDG utilization (K) and cerebral glucose metabolic rate (CGMR) were evaluated in a plasma glucose concentration range between 0.5 mM and 26 mM from the kinetic constant k1, k2, k3 obtained by the Sokoloff model of FDG accumulation. A decreasing set of standard FDG uptake values found with increasing blood glucose concentration was explained by competition between the plasma glucose and the radiopharmacon FDG. A similar trend was observed for the forward kinetic constants k1, and k3 in the entire concentration range studied. The same decreasing tendency of k2 was of a smaller magnitude and was reverted at the lowest glucose concentrations where a pronounced decrease of this backward transport rate constant was detected. Our kinetic data indicate a modulation of the kinetics of carbohydrate metabolism by the blood glucose concentration and report on a special mechanism compensating for the low glucose supply under conditions of extremely low blood glucose level.


Subject(s)
Brain/physiology , Glucose/metabolism , Hypoglycemia/metabolism , Animals , Blood Glucose/analysis , Brain/metabolism , Fluorodeoxyglucose F18/pharmacokinetics , Models, Animal , Rabbits , Radiopharmaceuticals/pharmacokinetics , Tomography, Emission-Computed
15.
J Virol Methods ; 94(1-2): 163-72, 2001 May.
Article in English | MEDLINE | ID: mdl-11337051

ABSTRACT

The immunogenic envelope antigen gp35-37 of human herpesvirus-8 (HHV-8) is encoded by orfK8.1. An ELISA is described using streptavidin capture of bacterially expressed and biotinylated recombinant K8.1 antigen. The antigen capture strategy provides a simple and reliable method, which does not require high yield production and purification of the recombinant antigen before the serological assay. The specificity and sensitivity of the K8.1 ELISA were validated by gp35-37 envelope antigen Western blot and anti-lytic membrane immunofluorescence assay using lytically induced HHV-8 infected BCBL-1 cells. Under the established ELISA conditions, eight of the 10 Kaposi's sarcoma patients and five of the 180 healthy blood donors had IgG antibodies to K8.1 envelope antigen.


Subject(s)
Glycoproteins/analysis , Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/virology , Viral Proteins/analysis , Biotin , Cloning, Molecular , Enzyme-Linked Immunosorbent Assay/methods , Fluorescent Antibody Technique, Indirect , Gene Expression , Glycoproteins/genetics , Glycoproteins/immunology , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/immunology , Humans , Recombinant Fusion Proteins/genetics , Sarcoma, Kaposi/blood , Sensitivity and Specificity , Tumor Cells, Cultured , Viral Proteins/genetics , Viral Proteins/immunology
17.
Orv Hetil ; 142(41): 2267-70, 2001 Oct 14.
Article in Hungarian | MEDLINE | ID: mdl-11760471

ABSTRACT

Acute myocarditis caused by infectious mononucleosis simulated myocardial infarction, initially the quantitative and qualitative blood picture was normal. Repeated blood and serological studies confirmed the diagnosis, which was altered by acute porphyria caused by infection. In each case of young patients with myocardial infarction and in older patient with coexisting infectious symptoms, myocarditis must be considered. Since the cardiac manifestation may precede the infectious disease symptoms, repeating the necessary examinations may be mandatory.


Subject(s)
Herpesvirus 4, Human/isolation & purification , Infectious Mononucleosis/complications , Myocarditis/diagnosis , Myocarditis/virology , Adult , Diagnosis, Differential , Electrocardiography , Enzyme-Linked Immunosorbent Assay , Humans , Male , Myocardial Infarction/diagnosis , Myocarditis/blood , Myocarditis/diagnostic imaging , Myocarditis/physiopathology , Tomography, Emission-Computed, Single-Photon
18.
Acta Microbiol Immunol Hung ; 48(3-4): 313-21, 2001.
Article in English | MEDLINE | ID: mdl-11791336

ABSTRACT

Primary human cytomegalovirus infection and the viral reactivation from latency are major complications in organ transplant recipients. In the peripheral blood the replicating virus can be detected either by nucleic acid based tests or by demonstrating the HCMV structural proteins in antigenemia test. We developed a quantitative competitive PCR method to assess the HCMV load in the peripheral blood. The viral load in nine healthy blood donors and in four renal transplant recipients with negative antigenemia test was in the same range: 5-124 (median: 18) HCMV copies/10(6) beta-globin copies for healthy blood donors and 16-48 (median: 37) HCMV copies/10(6) beta-globin copies for the transplant recipients. Three antigenemia positive renal transplant recipients had a HCMV load of 2.2 x 10(5)/10(6) beta-globin, 1.5 x 10(4)/10(6) beta-globin and 6.5 x 10(3)/10(6) beta-globin, respectively. In conclusion, the quantitative measurement of HCMV load in the peripheral blood correlated well with the routine HCMV antigenemia test. The DNA-based test, however can detect earlier the reactivation of the HCMV infection.


Subject(s)
Cytomegalovirus Infections/virology , Cytomegalovirus/genetics , Cytomegalovirus/isolation & purification , Polymerase Chain Reaction/methods , Viremia/virology , Base Sequence , Case-Control Studies , Cells, Cultured , Cloning, Molecular , Cytomegalovirus Infections/etiology , DNA Primers/genetics , DNA, Viral/genetics , Globins/genetics , Humans , Kidney Transplantation/adverse effects , Mutation , Viral Envelope Proteins/genetics , Viremia/etiology
19.
Anticancer Res ; 20(3B): 2161-7, 2000.
Article in English | MEDLINE | ID: mdl-10928171

ABSTRACT

BACKGROUND: The aim of this study was to determine the physical state of HPV16 DNA and to reveal any association between the physical state of virus DNA and pathologic or prognostic factors in HPV16 positive cervical cancers. The other aim was to estimate the role of p53 codon 72 polymorphism in disease progression. MATERIALS AND METHODS: The presence and physical state of HPV16 DNA was analysed by Southern blot hybridisation and E1-E2 specific PCRs in the primary tumours and pelvic lymph nodes of 85 cervical carcinoma patients. Results Integrated HPV16 DNA was found in 32 out of 41 (78%) primary tumours and 2 out of 22 (95%) lymph nodes carrying HPV16 DNA. No significant association was found between integration of virus DNA and course of the disease. There was a trend towards an association between disease recurrence and the presence of the p53 codon 72 arginine homozygous genotype (OR = 3.41, p = 0.23). CONCLUSION: The physical state of HPV16 DNA does not seem to play a major role as a prognostic indicator in Hungarian cervical cancer patients, while the p53 codon 72 genotype may have an impact on the clinical outcome of the disease.


Subject(s)
Carcinoma, Squamous Cell/virology , DNA, Viral/isolation & purification , Genes, p53 , Papillomaviridae/isolation & purification , Papillomavirus Infections/virology , Polymorphism, Genetic , Tumor Virus Infections/virology , Uterine Cervical Neoplasms/virology , Virus Integration , Adult , Aged , Alleles , Amino Acid Substitution , Blotting, Southern , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/mortality , Cell Differentiation , Codon/genetics , DNA Probes, HPV , Disease-Free Survival , Female , Genome, Viral , Genotype , Humans , Hungary , Life Tables , Lymph Nodes/virology , Lymphatic Metastasis , Middle Aged , Open Reading Frames , Papillomaviridae/classification , Papillomaviridae/genetics , Papillomavirus Infections/genetics , Polymerase Chain Reaction , Prognosis , Tumor Virus Infections/genetics , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/mortality
20.
J Clin Microbiol ; 38(1): 408-11, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10618127

ABSTRACT

The type specificity of the human papillomavirus (HPV) Hybrid Capture Tube (HCT) test was evaluated by using typing with PCR (MY09-MY11)-restriction fragment length polymorphism (RFLP) and sequencing. All samples HCT test positive for only low-risk HPV (n = 15) or only high-risk HPV (n = 102) were confirmed, whereas 9 of 12 HCT test double-positive samples contained only high-risk HPV types as determined by PCR-RFLP. Several high-risk HPV types (HPV-53, -58, -62, -66, -CP8304, and -MM4) not included in the HCT test were indeed detected, indicating a broader detection range with retained distinction between low-risk and high-risk HPV types.


Subject(s)
Cervix Uteri/virology , Papillomaviridae/classification , Papillomavirus Infections/diagnosis , Tumor Virus Infections/diagnosis , Cervix Uteri/pathology , Colposcopy , Female , Humans , Mass Screening , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , RNA Probes , Reagent Kits, Diagnostic , Sequence Analysis, DNA , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...